Atb Cap Markets Predicts Reduced Earnings for TerrAscend

TerrAscend Corp. (OTCMKTS:TSNDF) – Analysts at Atb Cap Markets reduced their FY2024 earnings estimates for shares of TerrAscend in a research report issued to clients and investors on Wednesday, November 6th. Atb Cap Markets analyst F. Gomes now expects that the company will post earnings per share of ($0.20) for the year, down from their prior estimate of ($0.14). The consensus estimate for TerrAscend’s current full-year earnings is ($0.14) per share. Atb Cap Markets also issued estimates for TerrAscend’s Q4 2024 earnings at ($0.03) EPS and FY2025 earnings at ($0.09) EPS.

Separately, Ventum Cap Mkts upgraded shares of TerrAscend to a “strong-buy” rating in a research note on Friday, August 9th.

TerrAscend Price Performance

TSNDF opened at $0.75 on Monday. The company has a 50 day simple moving average of $1.15 and a two-hundred day simple moving average of $1.35. The company has a current ratio of 1.35, a quick ratio of 0.69 and a debt-to-equity ratio of 0.81. TerrAscend has a 1-year low of $0.66 and a 1-year high of $2.45.

TerrAscend Company Profile

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.